Bystolic - 2007 FDA approvals

January 22, 2008 | By Maureen Martino

Drug: Bystolic (nebivolol)
Indication: Hypertension
Company: Forest Laboratories and Mylan
Approval Date: Decembe 18, 2007

Scoop: Bystolic is the 19th approved beta blocker available in the U.S. The drug's developers say it has "placebo-like" side effects, making compliance easier for patients with high blood pressure.

More News:
New "me-too" beta blocker dissed by experts. Report